Octavio-Charrez Merino

Dr. Octavio-Charrez Merino


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
OMOctavio-Charrez Merino
Octavio-Charrez Merino
PAPilar Alberdi
Pilar Alberdi
JLJosé Pérez de la Lastra
José Pérez de la Lastra
Jose De La FuenteJose De La Fuente
Jose De La Fuente
Ticks are obligate hematophagous ectoparasites that transmit a wide variety of pathogens to humans and animals. The incidence of tick-borne diseases has increased worldwide in both humans and domestic animals over the past years resulting in greater interest in the study of tick-host-pathogen interactions. Advances in vector and pathogen genomics and proteomics have moved forward our knowledge of the vector-pathogen interactions that take place during the colonization and transmission of arthropod-borne microbes. Tick-borne pathogens adapt from the vector to the mammalian host by differential gene expression thus modulating host processes. In recent years, studies have shown that targeting tick proteins by vaccination can not only reduce tick feeding and reproduction, but also the infection and transmission of pathogens from the tick to the vertebrate host. In this article, we review the tick-protective antigens that have been identified for the formulation of tick vaccines and the effect of these vaccines on the control of tick-borne pathogens.

1 December 2013 in Vaccine
Verified
Journal Article
Closed access
Jose De La FuenteJose De La Fuente
Jose De La Fuente
OMOctavio-Charrez Merino
Octavio-Charrez Merino

1 December 2013 in Vaccine
Verified
Journal Article
Closed access
OMOctavio-Charrez Merino
Octavio-Charrez Merino
SASandra Isabel Da Conceição Antunes
Sandra Isabel Da Conceição Antunes
Juan MosquedaJuan Mosqueda
Juan Mosqueda
JMJuan A. Moreno-Cid
Juan A. Moreno-Cid
JLJosé Pérez de la Lastra
José Pérez de la Lastra
Jose De La FuenteJose De La Fuente
Jose De La Fuente

1 November 2011 in Vaccine
Verified
Journal Article
Closed access
OMOctavio-Charrez Merino
Octavio-Charrez Merino
CAConsuelo Almazán
Consuelo Almazán
MCMario Canales
Mario Canales
MVMargarita Villar
Margarita Villar
JMJuan A. Moreno-Cid
Juan A. Moreno-Cid
Jose De La FuenteJose De La Fuente
Jose De La Fuente

8 November 2013 in Transboundary and Emerging Diseases
Verified
Journal Article
Open access
PDF file
Jose De La FuenteJose De La Fuente
Jose De La Fuente
JMJ. A. Moreno-Cid
J. A. Moreno-Cid
RGR. C. Galindo
R. C. Galindo
CAC. Almazan
C. Almazan
KKK. M. Kocan
K. M. Kocan
EBE. F. Blouin
E. F. Blouin
Diseases transmitted by arthropod vectors such as mosquitoes, ticks and sand flies greatly impact human and animal health, and therefore, their control is important for the eradication of vectorborne diseases (VBD). Vaccination is an environmentally friendly alternative for vector control that allows control of several VBD by targeting their common vector. Recent results have suggested that subolesin (SUB) and its orthologue in insects, akirin (AKR) are good candidate antigens for the control of arthropod vector infestations and pathogen infection. SUB was discovered as a tick‐protective antigen in Ixodes scapularis. Vaccination trials with recombinant SUB/AKR demonstrated effective control of arthropod vector infestations in various hard and soft tick species, mosquitoes, sand flies, poultry red mites and sea lice by reducing their numbers, weight, oviposition, fertility and/or moulting. SUB/AKR vaccination also reduced tick infection with tickborne pathogens, Anaplasma phagocytophilum, A. marginale, Babesia bigemina and Borrelia burgdorferi. The effect of vaccination on different hosts, vector species, developmental stages and vectorborne pathogen infections demonstrated the feasibility of SUB/AKR universal vaccines for the control of multiple vector infestations and for reduction in VBD.

9 March 2011 in Vaccine
Verified
Journal Article
Closed access
OMOctavio-Charrez Merino
Octavio-Charrez Merino
CAConsuelo Almazán
Consuelo Almazán
MCMario Canales
Mario Canales
MVMargarita Villar
Margarita Villar
JMJuan A. Moreno-Cid
Juan A. Moreno-Cid
Jose De La FuenteJose De La Fuente
Jose De La Fuente